Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party
- PMID: 1654074
- PMCID: PMC1977498
- DOI: 10.1038/bjc.1991.296
Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party
Abstract
Three hundred and sixty-nine patients in an MRC study of combination chemotherapy and radiotherapy for small-cell lung cancer of limited extent were asked to complete a Daily Diary Card which enabled an assessment of their quality of life to be made during and after treatment. The information derived from the card suggests that although cytotoxic chemotherapy has an adverse effect upon quality of life, this impairment only affects the first 2 or 3 days following each course of treatment, although there is also a small deterioration which may be associated with the 'nadir' effect of the blood counts about 10 days after each course. These results should assist physicians in counselling patients about the likely effects of treatment. Just over half of the patients (196) were subsequently randomised to either a further six courses of maintenance chemotherapy or no further chemotherapy, and it is also shown that the patients allocated to no maintenance chemotherapy experienced a gradually deteriorating quality of life, as opposed to the brief but more severe adverse effects which occurred following each course in the maintenance chemotherapy group; this supports the hypothesis of a palliative effect in this latter group. The findings demonstrate that the Daily Diary Card is a sensitive instrument capable of yielding useful information.
Similar articles
-
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.Br J Cancer. 1993 Dec;68(6):1157-66. doi: 10.1038/bjc.1993.497. Br J Cancer. 1993. PMID: 7505104 Free PMC article. Clinical Trial.
-
Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party.Respir Med. 1989 Jan;83(1):51-8. doi: 10.1016/s0954-6111(89)80060-5. Respir Med. 1989. PMID: 2479963 Clinical Trial.
-
Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.Eur J Cancer. 1990 Apr;26(4):484-92. doi: 10.1016/0277-5379(90)90022-l. Eur J Cancer. 1990. PMID: 2162692 Clinical Trial.
-
[Supportive care during chemotherapy for lung cancer in daily practice].Magy Onkol. 2012 Sep;56(3):159-65. Epub 2012 Aug 7. Magy Onkol. 2012. PMID: 23008823 Review. Hungarian.
-
Measurement and management of health-related quality of life in lung cancer.Clin Adv Hematol Oncol. 2004 Aug;2(8):533-40. Clin Adv Hematol Oncol. 2004. PMID: 16163227 Review.
Cited by
-
A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.Br J Cancer. 1992 Jun;65(6):934-41. doi: 10.1038/bjc.1992.196. Br J Cancer. 1992. PMID: 1377484 Free PMC article. Clinical Trial.
-
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.Br J Cancer. 2004 Dec 13;91(12):1996-2004. doi: 10.1038/sj.bjc.6602241. Br J Cancer. 2004. PMID: 15558071 Free PMC article. Clinical Trial.
-
Quality-of-life assessment in small cell lung cancer.Pharmacoeconomics. 1992 Sep;2(3):181-8. doi: 10.2165/00019053-199202030-00001. Pharmacoeconomics. 1992. PMID: 10147008 No abstract available.
-
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.Cochrane Database Syst Rev. 2015 Jan 14;1(1):CD002143. doi: 10.1002/14651858.CD002143.pub4. Cochrane Database Syst Rev. 2015. PMID: 25586198 Free PMC article.
-
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.Br J Cancer. 1993 Dec;68(6):1157-66. doi: 10.1038/bjc.1993.497. Br J Cancer. 1993. PMID: 7505104 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical